Treatment of lentigo maligna with tazarotene 0.1% gel

S Chimenti; Am Carrozzo; L Citarella; C De Felice; Ketty Peris

doi:10.1016/j.jaad.2003.07.005

Treatment of lentigo maligna with tazarotene 0.1% gel

S Chimenti, Am Carrozzo, L Citarella, C De Felice, Ketty Peris

Risultato della ricerca: Contributo in rivista › Articolo in rivista

12 Citazioni (Scopus)

Abstract

We report 2 elderly patients with facial lentigo maligna who experienced complete regression, both clinically and histopathologically, after once-daily topical treatment with tazarotene 0.1% gel for 6 to 8 months. After a follow-up period of 18 and 30 months, no recurrence was observed. We believe that tazarotene might be considered as an alternative medical approach in selected patients with lentigo maligna.

Lingua originale	English
pagine (da-a)	101-103
Numero di pagine	3
Rivista	Journal of the American Academy of Dermatology
Volume	50
DOI	https://doi.org/10.1016/j.jaad.2003.07.005
Stato di pubblicazione	Pubblicato - 2004

Keywords

Aged
Aged, 80 and over
Dermatologic Agents
Female
Gels
Humans
Hutchinson's Melanotic Freckle
Male
Nicotinic Acids

Accesso al documento

10.1016/j.jaad.2003.07.005

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{dc8c0ba7598148eda1e98d129bbe0524,

title = "Treatment of lentigo maligna with tazarotene 0.1% gel",

abstract = "We report 2 elderly patients with facial lentigo maligna who experienced complete regression, both clinically and histopathologically, after once-daily topical treatment with tazarotene 0.1% gel for 6 to 8 months. After a follow-up period of 18 and 30 months, no recurrence was observed. We believe that tazarotene might be considered as an alternative medical approach in selected patients with lentigo maligna.",

keywords = "Aged, Aged, 80 and over, Dermatologic Agents, Female, Gels, Humans, Hutchinson's Melanotic Freckle, Male, Nicotinic Acids, Aged, Aged, 80 and over, Dermatologic Agents, Female, Gels, Humans, Hutchinson's Melanotic Freckle, Male, Nicotinic Acids",

author = "S Chimenti and Am Carrozzo and L Citarella and {De Felice}, C and Ketty Peris",

year = "2004",

doi = "10.1016/j.jaad.2003.07.005",

language = "English",

volume = "50",

pages = "101--103",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Treatment of lentigo maligna with tazarotene 0.1% gel

AU - Chimenti, S

AU - Carrozzo, Am

AU - Citarella, L

AU - De Felice, C

AU - Peris, Ketty

PY - 2004

Y1 - 2004

N2 - We report 2 elderly patients with facial lentigo maligna who experienced complete regression, both clinically and histopathologically, after once-daily topical treatment with tazarotene 0.1% gel for 6 to 8 months. After a follow-up period of 18 and 30 months, no recurrence was observed. We believe that tazarotene might be considered as an alternative medical approach in selected patients with lentigo maligna.

AB - We report 2 elderly patients with facial lentigo maligna who experienced complete regression, both clinically and histopathologically, after once-daily topical treatment with tazarotene 0.1% gel for 6 to 8 months. After a follow-up period of 18 and 30 months, no recurrence was observed. We believe that tazarotene might be considered as an alternative medical approach in selected patients with lentigo maligna.

KW - Aged

KW - Aged, 80 and over

KW - Dermatologic Agents

KW - Female

KW - Gels

KW - Humans

KW - Hutchinson's Melanotic Freckle

KW - Male

KW - Nicotinic Acids

KW - Aged

KW - Aged, 80 and over

KW - Dermatologic Agents

KW - Female

KW - Gels

KW - Humans

KW - Hutchinson's Melanotic Freckle

KW - Male

KW - Nicotinic Acids

UR - http://hdl.handle.net/10807/57658

U2 - 10.1016/j.jaad.2003.07.005

DO - 10.1016/j.jaad.2003.07.005

M3 - Article

SN - 0190-9622

VL - 50

SP - 101

EP - 103

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

ER -

Treatment of lentigo maligna with tazarotene 0.1% gel

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo